Nordic ListingsIssuer Report
Generic Sweden AB: Quarterly Trading Report 2025 Q3
Generic Sweden AB: Quarterly Trading Report 2025 Q3https://view.news.eu.nasdaq.com/view?id=bd448fb24f6e2645517b2143b56335ed3&lang=en&src=omxlink
Generic Sweden AB: Quarterly Trading Report 2025 Q3
Earlier from Generic Sweden Ab
- GENI: Strong EBIT growth and improved margins in Q2 2025, led by SaaS and secure communication services
- GENI: SaaS-driven margin growth and strong DOCS adoption boost results amid CEO transition
- GENI: Record revenue and profit growth in 2024, fueled by SaaS and public sector wins
- GENI: Record revenue and EBITDA in Q3 2024, driven by SaaS growth and strong demand